| Helen H Luong, MD | |
|
1019 W La Palma Ave Unit B, Anaheim, CA 92801-3664 | |
| (714) 535-8900 | |
| (714) 778-1418 |
| Full Name | Helen H Luong |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 1019 W La Palma Ave Unit B, Anaheim, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104842319 | NPI | - | NPPES |
| 00A552690 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | A55269 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ahmc Anaheim Regional Medical Center | Anaheim, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Women's Care Ob/gyn Medical Group, Inc. | 3375571532 | 2 |
News Archive
Gene drives are genetic elements - found naturally in the genomes of most of the world's organisms - that increase the chance of the gene they carry being passed on to all offspring, and thus, they can quickly spread through populations. Looking to these natural systems, researchers around the world, including some Wyss Institute scientists, are developing synthetic gene drives that could one day be leveraged by humans to purposefully alter the traits of wild populations of organisms to prevent disease transmission and eradicate invasive species.
The United States regulator, Food and Drugs Administrator (FDA) has approved a machine called the Artas System for commercial use. According to manufacturers Restoration Robotics, Artas is "an interactive, computer assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting" by combining "several features including an interactive, image-guided robotic arm, special imaging technologies, small dermal punches and a computer interface." Artas can be used only on patients with straight brown or black hair at this stage.
Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.
Medicaid is one of the fastest growing parts of the state budget. To tackle rising health care costs, Gov. Deval Patrick's administration plans to stop paying hospitals with high rates of re-admissions when low-income patients return within 30 days.
› Verified 1 days ago
| Entity Name | Women's Care Ob/gyn Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295865400 PECOS PAC ID: 3375571532 Enrollment ID: O20050728001170 |
News Archive
Gene drives are genetic elements - found naturally in the genomes of most of the world's organisms - that increase the chance of the gene they carry being passed on to all offspring, and thus, they can quickly spread through populations. Looking to these natural systems, researchers around the world, including some Wyss Institute scientists, are developing synthetic gene drives that could one day be leveraged by humans to purposefully alter the traits of wild populations of organisms to prevent disease transmission and eradicate invasive species.
The United States regulator, Food and Drugs Administrator (FDA) has approved a machine called the Artas System for commercial use. According to manufacturers Restoration Robotics, Artas is "an interactive, computer assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting" by combining "several features including an interactive, image-guided robotic arm, special imaging technologies, small dermal punches and a computer interface." Artas can be used only on patients with straight brown or black hair at this stage.
Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.
Medicaid is one of the fastest growing parts of the state budget. To tackle rising health care costs, Gov. Deval Patrick's administration plans to stop paying hospitals with high rates of re-admissions when low-income patients return within 30 days.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Helen H Luong, MD 1019 W La Palma Ave Unit B, Anaheim, CA 92801-3664 Ph: (714) 535-8900 | Helen H Luong, MD 1019 W La Palma Ave Unit B, Anaheim, CA 92801-3664 Ph: (714) 535-8900 |
News Archive
Gene drives are genetic elements - found naturally in the genomes of most of the world's organisms - that increase the chance of the gene they carry being passed on to all offspring, and thus, they can quickly spread through populations. Looking to these natural systems, researchers around the world, including some Wyss Institute scientists, are developing synthetic gene drives that could one day be leveraged by humans to purposefully alter the traits of wild populations of organisms to prevent disease transmission and eradicate invasive species.
The United States regulator, Food and Drugs Administrator (FDA) has approved a machine called the Artas System for commercial use. According to manufacturers Restoration Robotics, Artas is "an interactive, computer assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting" by combining "several features including an interactive, image-guided robotic arm, special imaging technologies, small dermal punches and a computer interface." Artas can be used only on patients with straight brown or black hair at this stage.
Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.
Medicaid is one of the fastest growing parts of the state budget. To tackle rising health care costs, Gov. Deval Patrick's administration plans to stop paying hospitals with high rates of re-admissions when low-income patients return within 30 days.
› Verified 1 days ago
Jane K Hong, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1174 N Euclid St, Anaheim, CA 92801 Phone: 714-535-8900 Fax: 714-778-1418 | |
Byung Wha Chun, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3356 W Ball Rd, Suite: 115, Anaheim, CA 92804 Phone: 714-826-1274 Fax: 714-826-1274 | |
Ronald S. Kohorn, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Debra Rae Gierut, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Peggy L. Grau, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Patrick D. Roth, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Anne L. Hardebeck, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |